Position in ARWR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$163
New position
Shares Held
2
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#491
of 497 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Navigoe, LLC holds $17,913 across 27 Biotechnology names. ARWR ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELDN |
Eledon Pharmaceuticals, Inc.
|
1,005 | $3,959 | |
| 2 | EXEL |
Exelixis, Inc.
|
72 | $3,917 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 4 | INCY |
Incyte Corp
|
8 | $906 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
24 | $849 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3 | $722 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
8 | $626 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
10 | $572 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163 | 2 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||